Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Fengyuan Pharmaceutical Co., Ltd. is a prominent integrated pharmaceutical enterprise based in China, specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company is one of the world's largest producers of paracetamol (acetaminophen) APIs and is a leading manufacturer of large-volume parenteral (LVP) infusions. Its diversified portfolio includes finished dosages across several therapeutic areas, including cardiovascular, anti-infective, and digestive health, as well as an extensive retail pharmacy chain network. Publicly listed on the Shenzhen Stock Exchange, Fengyuan Pharmaceutical operates multiple GMP-certified manufacturing facilities and maintains a significant presence in both domestic Chinese and international export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fengyuan Pharmaceutical.